Effect of Daily Short Message System (SMS) Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia
NCT00873249 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 339
Last updated 2010-03-24
Summary
This study is a 6-month, multicenter, randomized study to assess the effect of daily SMS reminders sent during 3 months in the adherence to oral antipsychotic treatment in stabilized outpatients with schizophrenia.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-04-30
- Primary Completion
- 2010-03-31
- Completion
- 2010-03-31
Countries
- Spain
Study Locations
More Related Trials
-
Improving Medication Adherence Among People With Schizophrenia Through the Use of 2-way Pagers
NCT00392236 ·Status: COMPLETED ·Phase: NA
-
Medication Adherence in Older Adults With Serious Mental Illness
NCT00224380 ·Status: COMPLETED ·Phase: NA
-
An Adherence Study of Antipsychotic Medication in Outpatients With Schizophrenia or Schizoaffective Disorder
NCT00861003 ·Status: UNKNOWN
-
A Smartphone App on Medication Adherence
NCT05892120 ·Status: UNKNOWN
-
Do Self-Report and Physician Impressions of Adherence to Oral Antipsychotic Medication Agree With Objective Data?
NCT00223522 ·Status: COMPLETED
-
Patient-Centered Medication Adherence Intervention for Schizophrenia
NCT00144027 ·Status: COMPLETED ·Phase: NA
-
The Effects AZD8529 on Cognition and Negative Symptoms in Schizophrenics
NCT00986531 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of Adherence Therapy for Schizophrenia
NCT01780116 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Impact of Caregiver Beliefs on Adherence to Antipsychotic Medications in Patients With Schizophrenia
NCT03471013 ·Status: TERMINATED
-
A Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia to Describe Medical Resource Utilization and Burden of Illness
NCT01959659 ·Status: COMPLETED
-
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
NCT00088634 ·Status: COMPLETED ·Phase: PHASE2
-
Cognitive Adaptive Training for Improving Medication Adherence, Symptoms, and Function in People With Schizophrenia
NCT00455663 ·Status: COMPLETED ·Phase: NA
-
Theory Based Integrated Program on Medication Adherence Among Community Dwelling Schizophrenia
NCT05835583 ·Status: COMPLETED ·Phase: NA
-
A Registry of Treatment Adherence for Patients With Schizophrenia
NCT00283517 ·Status: COMPLETED
-
Safety and Efficacy Study for Cognitive Deficits in Adult Subjects With Schizophrenia
NCT01095562 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of Schizophrenia
NCT01029769 ·Status: COMPLETED ·Phase: NA
-
Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia
NCT00086593 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Adherence Therapy on Medication Adherence in Patients With Schizophrenia Spectrum Disorder
NCT04022577 ·Status: COMPLETED ·Phase: NA
-
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
NCT00528905 ·Status: COMPLETED ·Phase: PHASE2
-
Texting for Relapse Prevention
NCT02819349 ·Status: COMPLETED ·Phase: NA
-
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
NCT01834638 ·Status: TERMINATED ·Phase: PHASE2
-
A Physical Dependence Study in Schizophrenia
NCT01452919 ·Status: COMPLETED ·Phase: PHASE3
-
Mobile Enhancement of Motivation in Schizophrenia
NCT03059771 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate The Effects of RO5545965 in Participants With Negative Symptoms of Schizophrenia Treated With Antipsychotics
NCT02824055 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of Atypical Antipsychotics on Anhedonic Features in Patients With Schizophrenia
NCT01160679 ·Status: COMPLETED